Hepatitis B Prevention Strategies: A Benefit-Cost Analysis of Immune Serum Globulin, Hepatitis B Immune Globulin, and Hepatitis B Vaccine in the Military

1986 ◽  
Vol 2 (6) ◽  
pp. 359-366 ◽  
Author(s):  
W. Douglas Everett
BMJ ◽  
1976 ◽  
Vol 2 (6026) ◽  
pp. 19-20 ◽  
Author(s):  
J P Wauters ◽  
M Leski

1974 ◽  
Vol 290 (13) ◽  
pp. 701-706 ◽  
Author(s):  
Wolf Szmuness ◽  
Alfred M. Prince ◽  
Morris Goodman ◽  
Carlos Ehrich ◽  
Rubin Pick ◽  
...  

PEDIATRICS ◽  
1976 ◽  
Vol 58 (4) ◽  
pp. 629-630
Author(s):  
Saul Krugman

The decision to use immune serum globulin (ISG) for household contacts of symptomatic or asymptomatic carriers of hepatitis B virus should be dependent upon at least two factors: (1) the efficacy of the ISG preparation, and (2) the risk of acquiring disease following the exposure. Efficacy of ISG. It is clear that conclusions based on studies which were conducted in the 1950's and 1960's are no longer valid today. At that time, specific tests for the identification of hepatitis B infection were not available.


The Lancet ◽  
1975 ◽  
Vol 306 (7942) ◽  
pp. 939-941 ◽  
Author(s):  
L.B Seeff ◽  
E.C Wright ◽  
J.D Finkelstein ◽  
H.B Greenlee ◽  
J Hamilton ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document